Stock Information
Janux Therapeutics Inc (JANX)
Ticker Symbol: JANX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,234.32 mil
Piotroski score: 6
PE Ratio: N/A
EPS (TTM): -1.64
Revenue (TTM): $0.38 M
Dividend Yield: N/A
ROE: -10.79%
Latest News
-
Janux Therapeutics (JANX) Advances Prostate Cancer Trial While Valuation Still Looks Pricey
Sun, Sep 27, 2026 3:07 PM
Key Financials
Financial data not available